Phase I and pharmacological study of the oral farnesyltransferase inhibitor SCH 66336 given once daily to patients with advanced solid tumours.

A Awada, Ferry Eskens, M Piccart, DL Cutler, Ate van der Gaast, H Bleiberg, J Wanders, MN Faber, P Statkevich, P Fumoleau, Jaap Verweij

Research output: Contribution to journalArticleAcademicpeer-review

58 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2272-2278
Number of pages7
JournalEuropean Journal of Cancer
Publication statusPublished - 2002

Cite this